Newswise — CHICAGO— The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill. Mexican Americans consistently had the highest percentage of MAFLD,…Read More
Prevalence of metabolic associated fatty liver disease is increasing
